Michael Tveden Gundesen

Also affiliated with Odense University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 Study”.

Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 Study

Journal of Bone and Mineral Research(2020)10.1002/jbmr.4807

N/A

0.345DataRank · unranked

9 citations

Michael Tveden Gundesen, Christian Walther Andersen, Anne Lerberg Nielsen, Hanne Elisabeth Højsgaard Møller, Pernille Just Vinholt +7 more

Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progression

Leukemia(2025)10.1038/s41375-025-02572-z

N/A

0.253DataRank · unranked

4 citations

Marta Diaz‐delCastillo, Angelo Jose Guilatco, Bilal Mohamad El-Masri, Fatima Mustapha, Michael Tveden Gundesen +13 more

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma

Oncotarget(2024)10.18632/oncotarget.28548

N/A

0DataRank · unranked

8 citations

Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund +4 more

Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical study

Bone(2025)10.1016/j.bone.2025.117660

N/A

0DataRank · unranked

0 citations

Marta Diaz‐delCastillo, Michael Tveden Gundesen, Oriane Cédile, Christian Walther Andersen, Anne Lerberg Nielsen +10 more